www.pharmablog.nl
Weblog met nieuws over de pharmaceutische industrie
Archive for March, 2010
Fat Clue To TB Awakening
Author: admin30 Mar
The factors instrumental in triggering latent tuberculosis (TB) infection to progress into active disease have long remained elusive to researchers. New insight into the mystery is provided by Professor David Russell, speaking at the Society for General Microbiology’s spring meeting in Edinburgh. His work could help develop innovative strategies for treating the disease…
Lees meer..
BIO Supports Extension Of Cellulosic Biofuel Producer Tax Credit, Requests Parity For Algae And Biobased Products
Author: admin30 Mar
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization (BIO) thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit…
Lees meer..
Cincinnati judge throws out Plavix suit
Author: admin30 Mar
An antitrust lawsuit filed by Kroger Co. and other pharmacy operators against Bristol-Myers Squibb and Sanofi-Aventis has been thrown out by a federal judge in Cincinnati. (KR) (BMY) (SNY)
Oxygen Biotherapeutics launches product, plans $75M stock offering
Author: admin30 Mar
Shares of Oxygen Biotherapeutics soared Monday after the Durham-based company said that it has begun distribution of a newly formulated Dermacyte Oxygen gel for the beauty and skin care market.
Stormont-Vail HealthCare joins Midwest Cancer Alliance Partners Advisory Board
Author: admin30 Mar
Topeka-based Stormont-Vail HealthCare has joined the Midwest Cancer Alliance Partners Advisory Board, the University of Kansas Cancer Center said Monday.
Prime Therapeutics names former Cigna exec CEO
Author: admin30 Mar
Prime Therapeutics has named Eric Elliott, a former Cigna Corp. executive, to the position of president and CEO.
SSM St. Mary’s Health Center starts $7M overhaul
Author: admin30 Mar
SSM St. Mary’s Health Center in Richmond Heights plans to overhaul its main entranceway on Clayton Road as part of $7 million in upgrades planned in 2010.
FDA raises questions about Cephalon’s Nuvigil for jet lag disorder
Author: admin30 Mar
The Food and Drug Administration raised additional questions Monday concerning Cephalon Inc.’s efforts to gets its sleep disorder drug Nuvigil approved as a treatment for jet lag disorder. (CEPH)
Emory, Zirius partner on anti-viral drugs
Author: admin30 Mar
The Emory Institute of Drug Discovery and Zirus Inc. are joining forces to develop novel compounds to treat infectious disease.
Polsinelli Shughart lands role as primary outside law firm for Catholic Health Initiatives
Author: admin30 Mar
Polsinelli Shughart PC has landed a significant legal account from Denver-based Catholic Health Initiatives, the nation’s second-largest Catholic health care system.
